The Journal of the Acoustical Society of America · 2014 · 24 citations · 45 references
Veterinary MedicineBioengineeringBiomedical EngineeringAcousticsUltrasonographyUltrasoundCavitationContrast MediaContrast-enhanced UltrasoundDiagnostic UltrasonographyUltrasonicsUltrasound PhysicsAcoustic CavitationAcoustic Detection Of CavitationCavitation DetectionLiposomesUltrasonic AcousticsUltrasonic ImagingUltrasound Contrast AgentsUltrasound Therapy
Ultrasound contrast agents (UCAs) can be employed to nucleate cavitation to achieve desired bioeffects, such as thrombolysis, in therapeutic ultrasound applications. Effective methods of enhancing thrombolysis with ultrasound have been examined at low frequencies (<1 MHz) and low amplitudes (<0.5 MPa). The objective of this study was to determine cavitation thresholds for two UCAs exposed to 120-kHz ultrasound. A commercial ultrasound contrast agent (Definity(®)) and echogenic liposomes were investigated to determine the acoustic pressure threshold for ultraharmonic (UH) and broadband (BB) generation using an in vitro flow model perfused with human plasma. Cavitation emissions were detected using two passive receivers over a narrow frequency bandwidth (540-900 kHz) and a broad frequency bandwidth (0.54-1.74 MHz). UH and BB cavitation thresholds occurred at the same acoustic pressure (0.3 ± 0.1 MPa, peak to peak) and were found to depend on the sensitivity of the cavitation detector but not on the nucleating contrast agent or ultrasound duty cycle.
45
Deaths: preliminary data for 2003.
Donna L. Hoyert, Hsiang-Ching Kung, Betty Smith · PubMed · 2005 · 1.7K citations
National Vital Statistics Reports NCHS.pdf
Dl Hoyert · Medical Entomology and Zoology · 2012 · 984 citations
Acoustical properties of the human skull
F. J. Fry, James E. Barger · The Journal of the Acoustical Society of America · 1978 · 615 citations
Natural Sciences, Anatomy, Physics +15